DARUNAVIR FORMULATIONS
This invention relates to solid oral dosage forms of the HIV inhibitor darunavir and/or a pharmaceutically acceptable salt or solvate thereof, and combination formulations thereof.
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English |
Published |
12.08.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | This invention relates to solid oral dosage forms of the HIV inhibitor darunavir and/or a pharmaceutically acceptable salt or solvate thereof, and combination formulations thereof. |
---|---|
Bibliography: | Application Number: US202117242218 |